<DOC>
	<DOC>NCT03056352</DOC>
	<brief_summary>Post-traumatic headache is common. We are determining short and longer-term outcomes among patients treated for post-traumatic headache with IV metoclopramide.</brief_summary>
	<brief_title>Metoclopramide for Post-Traumatic Headache. A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Post-Traumatic Headache</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>Traumatic injury to the head has occurred Headache has developed within 7 days of injury to the head Headache is not better accounted for by another diagnosis (eg, previous history of migraine or tensiontype headache) The headache must be rated as moderate or severe in intensity at the time of initial evaluation. The plan of the attending emergency physician must include treatment with parenteral metoclopramide. Patients will be excluded if more than ten days have elapsed since the head trauma, if the headache has already been treated with an antidopaminergic medication, or for medication contraindications including pheochromocytoma, seizure disorder, Parkinson's disease, use of MAO inhibitors, and use of antirejection transplant medications. Patients will not be excluded for pregnancy or breastfeeding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>